Skip to main content
OpenTrials
Completed

NCT Number: NCT01081327

Warfarin - How Good Are we at Maintaining Target Range ?

Patients with atrial fibrillation are often anticoagulated with Warfarin. Warfarin has a narrow therapeutic window requiring frequent monitoring. This study aims to investigate the incidence of adverse events in the "real world" for patients receiving Warfarin for lone atrial fibrillation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre for Cardiovascular and Lung Biology, Univeristy of Dundee

Dundee, DD1 9SY, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prescription for Warfarin
  • Atrial Fibrillation

Exclusion criteria

  • Other conditions associated with increased risk of embolisation e.g. rheumatic valve disease, atrial mixoma.
  • Conditions with increased risk of bleeding.

Treatment and study plan

Primary outcomes

  1. Bleeding Complication

    Time frame: 10 years

    Any bleeding event requiring hospitalisation and / or blood transfusion. Any death attributable to bleeding i.e. Intracerebral bleed.

  2. Cardiovascular outcome

    Time frame: 10 years

    Ischaemic event e.g. Cerebral infarction / Myocardial infarction / death attributed to ischaemic event

Sponsors and collaborators

Lead sponsor

University of Dundee

Other

Collaborators

  • NHS Tayside

Registry information

Official study title

Observational Record Linkage Study Investigating Incidence of Adverse Events in Patients Anti-coagulated for Lone Atrial Fibrillation.

Important dates

Study start
2010
Primary completion
2016
Study completion
2016
First posted
Mar 5, 2010
Registry last updated
Dec 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.